Search
for
Sort by
Research 511–540 of 1000+
- Recent Developments in Luteolin-Loaded Nanoformulations for Enhanced Anti-Carcinogenic Activities: Insights from In Vitro and In Vivo Studies
- Pathologic Diagnosis of Central Centrifugal Cicatricial Alopecia on Horizontal Sections
- The Double-Edged Proteins in Cancer Proteomes and the Generation of Induced Tumor-Suppressing Cells (iTSCs)
- [Clinical findings with a low-dosed antiandrogene (cyproteronacetate) and aethinyloestradiol women with virilising symptoms (author's transl)].
- A Case of Acrodermatitis Enteropathica
- Cutaneous lupus erythematosus induced by tislelizumab
- Discreet monilethrix: De novo mutation on the example of polish families
- Expert consensus for prevention, diagnosis and management of persistent chemotherapy-induced alopecia.
- Pengaruh Ekstrak Metanol Batang Etlingera alba (Blume) A. D. Poulsen Terhadap Penekanan Genicaspase-3 sebagai Penanda Apoptosis pada Lini Sel Kanker Payudara T47D Secara In Vitro
- Pathogenesis and regenerative therapy in vitiligo and alopecia areata: focus on hair follicle
- Coexisting trichorrhexis nodosa and pili annulati: a case report of hair shaft abnormalities in a syrian family
- Secondary Adrenal Insufficiency : A Case Report
- Trichoscopy in alopecia areata and trichotillomania
- Efficacy and safety of baricitinib in patients with alopecia areata: evidence to date
- Alopecia – focus on negative emotional impact
- CPC12 Coinheritance of <i>BRCA2</i> and <i>CYLD</i> germline pathogenic variants associated with targetable metastatic malignant cylindroma
- [Prophylaxis of recurring low-flow priapism : Experimental botulinum neurotoxin injection into the ischiocavernosus muscle].
- Menopause - Andropause - Anti-Aging 2008, 11.-13. Dezember 2008, Wien - Abstracts
- Clin-Alert
- 503 Use of low-dose spironolactone in female pattern hair loss in a specialty alopecia clinic
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- Medicine Update
- Hair perms/straighteners and styling agents
- Supportive Oncodermatology: Addressing dermatologic adverse events associated with oncologic therapies
- Oral minoxidil for late alopecia in cancer survivors
- Tamoxifen for flutamide/finasteride-induced gynecomastia
- The Influence of Various Parameters on the Success of Sensor-Controlled Scalp Cooling in Preventing Chemotherapy-Induced Alopecia
- Questions and Answers
- Eyelash Preservation During Chemotherapy and Topical Prostaglandin Therapy
- Thermal Induced Changes in Cuticle and Cortex to Chemically Treated Hair